专利检索 ap:("Viracta Therapeutics, Inc.") AND inv:"Preston DANIELS" 第 1 页

1.

发明申请
EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY 审中-公开

公开(公告)号：US20200368280A1

公开(公告)日：2020-11-26

申请号：US16961200

申请日：2019-01-11

申请人： Viracta Therapeutics, Inc.

发明人： Marshelle WARREN , Preston DANIELS

IPC分类号： A61K35/17 , A61P35/02 , A61K31/506 , A61K39/395 , A61P31/18 , C12N5/0783

摘要： Described herein are methods and compositions useful for augmenting cell-based immunotherapies. The augmented cell-based immunotherapies can be used to treat individuals with cancer and chronic viral infections.